The discovery of RIP1 kinase inhibitor GSK2982772 i
GSK2982772 is capable of specifically binding to RIP1 and efficiently blocks TNF-dependent cellular pathways. As a new anti-inflammatory compound, it can reduce the spontaneous production of cytokines in ulcerative colitis tissue. Due to its...英国华人论坛